Malalties hepàtiques víriques, genètiques i immuno-mediades
Publicacions destacades
-
Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries
Razavi, Homie A; Buti, Maria; Terrault, Norah A; Zeuzem, Stefan; Yurdaydin, Cihan;(...)Villalobos-Salcedo, Juan Miguel; Voeller, Alexis S; Yang, Hwai-, I; Yu, Ming-Lung; Zuckerman, Eli.Referència:Journal Of Hepatology 2023.
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predni(so)lone administration
Diaz-Gonzalez, Alvaro; Hernandez-Guerra, Manuel; Perez-Medrano, Indhira; Sapena, Victor; Riveiro-Barciela, Mar;(...)Lopez, Carmen; Alvarez-Navascues, Carmen; Garcia-Retortillo, Montserrat; Crespo, Javier; Londono, Maria-Carlota.Referència:Hepatology 2023.
-
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS
Pallett, LJ; Swadling, L; Diniz, M; Davies, J; Kucykowicz, S;(...)Davidson, BR; Perez-del-Pulgar, S; Al-Akkad, W; Mazza, G; Bengsch, B.Referència:Nature 2023.
-
Non-invasive tests for clinically significant portal hypertension after HCV cure
Semmler, Georg; Lens, Sabela; Meyer, Elias L; Meyer, Elias L; Baiges, Anna;(...)Hernandez-Gea, Virginia; Reiberger, Thomas; Bosch, Jaume; Pagan, Juan Carlos Garcia; Mandorfer, Mattias.Referència:Journal Of Hepatology 2022.
-
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Sanduzzi-Zamparelli, M; Sapena, V; Iserte, G; Granel, N; Llarch, N;(...)Díaz, A; Fuster-Anglada, C; Ayuso, C; Rimola, J; Torres, F.Referència:Journal Of Hepatology 2022.
-
Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)
Hirode, G; Choi, HSJ; Feld, J; Hansen, BE; Janssen, HLA;(...)Sonneveld, MJ; Chien, RN; Jeng, WJ; Hsu, YC; Cornberg, M.Referència:Gastroenterology 2022.
-
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
Taubert, Richard; Engel, Bastian; Diestelhorst, Jana; Hupa-Breier, Katharina L; Behrendt, Patrick;(...)Maasoumy, Benjamin; Witte, Torsten; Wedemeyer, Heiner; Manns, Michael P; Jaeckel, Elmar.Referència:Hepatology 2022.
-
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
García-López, M; Lens, S; Rodríguez-Tajes, S; Mariño, Z; Bartres, C;(...)Maini, MK; Testoni, B; Zoulim, F; Lozano, JJ; Rodríguez-Frías, F.Referència:Journal Of Hepatology 2021.
-
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Lens, Sabela; Baiges, Anna; Alvarado-Tapias, Edilmar; LLop, Elba; Martinez, Javier;(...)Hernandez-Gea, Virginia; Bosch, Jaume; Villanueva, Candid; Carlos Garcia-Pagan, Juan; Forns, Xavier.Referència:Journal Of Hepatology 2020.
-
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future
Rodriguez-Tajes, Sergio; Pocurull, Anna; Castillo, Joaquin; Casanova, Gherzon; Vega, Laia;(...)Marino, Zoe; Londono, Maria-Carlota; Forner, Alejandro; Torres, Ferran; Forns, Xavier.Referència:Journal Of Hepatology 2020.